Dissimilar invasive and metastatic behavior of vincristine and doxorubicin-resistant cell lines derived from a murine T cell lymphoid leukemia

Clinical and Experimental Metastasis

Volumn 19, Issue 4, 2002, Pages 283-290

  Lopes, Eloisi C ^a   Ernst, Glenda ^a   Aulicino, Paula ^a   Vanzulli, Silvia ^b   García, Mariana ^a   Alvarez, Elida ^a   Hajos, Silvia E ^a  

^a IDEHU CONICET ^*  (Argentina)

^b ACADEMIA NACIONAL DE MEDICINA   (Argentina)

Author keywords

CD44; Doxorubicin; Hyaluronic acid; Lymphoid leukemia; Metastasis; Multidrug resistance; Vincristine

Indexed keywords

CD18 ANTIGEN; CD24 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; DOXORUBICIN; HERMES ANTIGEN; HYALURONIC ACID; INTERLEUKIN 2 RECEPTOR; PHORBOL ESTER; SULFORHODAMINE B; VINCRISTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL ADHESION; CONTROLLED STUDY; HISTOPATHOLOGY; LYMPHATIC LEUKEMIA; METASTASIS; MORTALITY; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; T CELL LEUKEMIA;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIGENS, CD44; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL DIVISION; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HYALURONIC ACID; LYMPHOMA, T-CELL; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED; VINCRISTINE;

EID: 0036284118     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015548706673     Document Type: Article

References (27)

1. Reversal of multidrug resistance by tyrosin-kinase inhibitors in a non-P-glycoprotein-mediated multidrug-resistant cell line
2. P-glycoproteins: Mediators of multidrug resistance
3. Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma-diagnostic and prognostic implications
4. CD44 in malignant disorders
5. CD44: Structure, function and association with the malignant process
6. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons
7. CD44 exon 6 expression as a possible early prognostic factor in primary node negative breast carcinoma
8. Over-expression of human CD44s in murine 3T3 cells: Selection against during primary tumorigenesis and selection for during micrometastasis
9. CD44 isoforms impact on lymphocyte activation and differentiation
10. A novel ligand for CD44 is serglycin, a hematopoietic cell lineage-specific proteoglycan
11. Receptor-ligand interaction between CD44 and osteopontin (Eta- 1)
12. Variant exons v6 and v7 together expand the repertoire of glycosaminoglycans bound by CD44
13. Forms and functions of CD44
14. Membrane protein glycosylaion and CD44 content in the adhesion of human ovarian cancer cells to hyaluronan
15. Modulator activity of PSC 833 and cyclosporin-A in vincristine and doxorubicin-selected multidrug resistant murine leukemic cells
16. Hyaluronan-independent lodgment of CD44+ lymphoma cells in lymphooid organs
17. Responsiveness to hormone, growth factor and drug treatment of a human breast cancer cell line: Comparison between early and late cultures
18. Sequential emergence of distinct resistance phenotypes in murine erythroleukemia cells under adriamycin selection: Decreased anthracycline uptake precedes increased P-glycoprotein expression
19. Correlation between decreased apoptosis and multidrug resistance (MDR) in murine leukemic T cell lines
20. CD44 receptor of lymphoma cells: Structure-function relationship and mechanism of activation
21. Activation and interaction of CD44 and hyaluronan in immunological systems
22. Expression of CD44 splice variants in spontaneous murine tumors
23. CD44 and its interaction with extracellular matrix
24. CD44 structure and fuction
25. A role for the cell adhesion molecule CD44 and sulfation in leukocyte-endothelial cell adhesion during an inflammatory response?
26. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronan bearing cells
27. Chromosomes studies of murine T-cell lymphoid leukemia and derived cell lines